switching between glp 1 agonists chart Schematic illustration of monoagonists, dual and triple Overview of GLP-1 Receptor Agonists
Description
Long-term effects of intensive glucose lowering on cardiovascular outcomes

A meta-analysis across randomized controlled trials found significant reductions in body weight averaging 12.4%, BMI by 4.0 kg/m2, and waist circumference by 8.0 cm

Minimize alcohol consumption, as it can contribute to dehydration

Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin-pump-treated patients with type 1 diabetes: the Lira Pump trial-a randomized, double-blinded, placebo-controlled trial

I feel healthier, stronger, and more confident than I have in years

Data availability This study is based in part on data from the Clinical Practice Research Datalink obtained under licence from the UK Medicines and Healthcare products Regulatory Agency